Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.00	31.01	41.91
Graham Fair Price	-20.91	110324.76	139486.05
PEG	-226.45	< 0.005	< 0.005
Price/Book	6.95	0.23	0.22
Price/Cash Flow	-1280.80	-47.08	-3.41
Prices/Earnings	77.39	1.42	-0.80
Price/Sales	-9.79	0.18	0.20
Price/FCF	-1280.80	-47.08	-3.41
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	38.09	0.08	0.06
Operating Margin	44.23	0.07	0.05
ROA	-38.44	< 0.005	-0.01
ROE	-0.07	0.04	-39.71
ROIC	< 0.005	0.01	16.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.02	80.34
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.29	0.74	-42.58
EPS QOQ	-2.97	1.61	-45.66
FCF QOQ	-1.88	0.92	-50.89
Revenue QOQ	0.34	0.21	-39.68
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	45.42	27.99	-38.37
Days Sales Outstanding (DSO)	61.23	53.52	-12.59
Inventory Turnover	1.98	3.22	62.27
Debt/Capitalization	0.80	0.80	0.23
Quick Ratio	0.36	0.41	14.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	112167.30	114256.50	1.86
Cash	9686.21	12127.63	25.21
Capex	-4361.36	-5727.82	-31.33
Free Cash Flow	-7215.19	-569.27	92.11
Revenue	123568.65	149231.15	20.77
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.77	0.78	1.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	39.81	29.37	-26.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating